Tim Mitchell

Vice President Quality, Compliance & Manufacturing Technology - Cell Therapy Oncology Development at Innovative Cellular Therapeutics (ICT) in December 2018 to April 2020

Head of Corporate Quality - Cell Therapy Technologies and Targeted Nuclear Oncology at Endocyte (Novartis) in October 2017 to December 2018

Vice President Quality Operations & Regulatory Affairs – Cell Therapy (CAR-T) Manufacturing at Cognate BioServices in August 2016 to September 2017

Site Head Quality Operations - Oncology Commercial Sterile Operations at Celgene (Bristol Myers Squibb) in February 2012 to August 2016

Vice President, Quality, Compliance & Regulatory Affairs at Coldstream Laboratories, Inc. in January 2005 to January 2012

Director, Aseptic Alpha1 Protease Inhibitor Manufacturing Operations - Biopharmaceuticals at Aventis Behring in January 2001 to January 2005

Sr. Manager, Technical Manufacturing Operations, Regulatory & Quality Assurance at NABI Biopharmaceuticals, Inc. in January 1997 to January 2001

Manager, Corporate Quality & Technology Transfer/Site Start Up at SyStemix, Inc. in January 1994 to January 1997

Operations Site Lead - Biosynthetic Manufacturing Technical Services at Eli Lilly and Company in January 1991 to January 1994

Sr. Biochemist - Biosynthetic Technical Services at Eli Lilly and Company in January 1987 to January 1991

Process Engineer - Biochemical Engineering & Process Development at Eli Lilly and Company in January 1984 to January 1987

Antibiotic Manufacturing Biochemist - Antibiotic Production at Eli Lilly and Company in January 1980 to January 1984